STOCK TITAN

Cingulate (CINGW) SEC Filings, Aug 2025-Feb 2026

CINGW NASDAQ
Rhea-AI Summary

Cingulate Inc. director Peter J. Werth reported transactions made through Werth Family Investment Associates LLC in connection with the company’s private placement. The LLC purchased 19,455 shares of common stock at $5.04 per share and 15,564 warrants at $0.10 per warrant on February 6, 2026. These common shares bring the LLC’s indirectly held common stock to 117,449 shares, while Werth also holds 92 shares directly. The warrant to purchase 15,564 common shares becomes exercisable only after stockholders approve the private placement, as required by Nasdaq rules, and will expire 36 months after the exercise date.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-37.23%
Tags
insider
-
Rhea-AI Summary

Cingulate Inc. director and Chief Executive Officer Shane J. Schaffer reported indirect purchases through Fountainhead Shrugged, LLC. On February 6, 2026, the LLC acquired 6,809 shares of common stock at $5.04 per share, bringing its indirectly held common stock to 10,175 shares, while Schaffer also holds 173 shares directly.

On the same date, Fountainhead Shrugged, LLC acquired warrants for 5,447 shares of common stock at $0.10 per warrant. The filing notes these common shares and warrants were obtained in a private placement and that the warrant becomes exercisable once stockholders approve the private placement, with an expiration 36 months after the exercise date.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-37.23%
Tags
insider
-
Rhea-AI Summary

Cingulate Inc.'s EVP and Chief Medical Officer, Matthew Brams, reported buying company securities in a private placement. On 02/06/2026, he purchased 1,946 shares of common stock at $ 5.04 per share, bringing his directly held common stock to 4,656 shares.

He also acquired a warrant to purchase 1,556 shares of common stock at $ 0.1 per warrant. The warrant becomes exercisable only after stockholders approve the private placement under Nasdaq rules and will expire 36 months after the exercise date.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-37.23%
Tags
insider
Rhea-AI Summary

Cingulate Inc. reported multiple unregistered issuances of common stock from January 6 to February 5, 2026, exchanging shares with a lender to retire portions of outstanding debt. Individual transactions included 68,965 shares at $4.35 per share on January 6 and 41,597 shares at $6.01 per share on February 5.

The company also completed a portion of a previously announced private placement on February 6, 2026, receiving gross proceeds of $6.5 million. Cingulate expects to close the remaining $5.5 million of this private placement as soon as practicable after satisfying closing conditions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-17.37%
Tags
current report
-
Rhea-AI Summary

Cingulate Inc. entered into a private placement with several investors, including certain officers and directors, to raise approximately $12,000,000. The deal includes 2,147,471 common shares, 973 shares of Series A convertible preferred stock with a $1,000 stated value, and warrants to buy 1,868,482 common shares. The combined price is $5.14 per common share, including $0.10 per warrant share, and the company plans to use the net proceeds for working capital and general corporate purposes.

The Series A preferred carries a 12.0% annual cumulative dividend on its stated value and will automatically convert into common stock at a $5.04 conversion price after stockholder approval. Investors receive warrants exercisable at $5.04 per share. Cingulate agreed to file a resale registration statement within 60 days of closing. Falcon Creek may designate up to two of seven board members, subject to ownership thresholds, while investors accept a 180-day lock-up and a 24‑month standstill that limits their ownership to 40% on an as-converted basis.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.35%
Tags
current report
-
Rhea-AI Summary

Cingulate Inc. reported that between July 22 and September 5, 2025, it issued unregistered shares of common stock to a lender in exchange for portions of outstanding debt. These transactions were made in reliance on the exemption provided by Section 3(a)(9) of the Securities Act.

On July 30, 2025, the company issued 58,139 shares at a value of $5.16 per share. On August 12, it issued 74,074 shares at $4.05 per share, and on August 21, it issued 64,102 shares at $3.90 per share. On August 29, 63,451 shares were issued at $3.94 per share, followed by 65,963 shares at $3.79 per share on September 5.

These exchanges reduce the company’s debt obligations while increasing the number of common shares held by the lender, meaning some creditors are becoming equity holders instead of remaining purely lenders.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-19.86%
Tags
current report
Rhea-AI Summary

Cingulate Inc. reported updates to executive compensation and a senior departure. The board had previously appointed John A. Roberts as Executive Chairman and placed CEO Shane Schaffer on administrative leave effective August 14, 2025. On August 22, 2025, the board set Mr. Roberts’ compensation at a cash retainer of $10,000 per month during his term as Executive Chairman, in lieu of non-employee director pay, and reduced Dr. Schaffer’s salary to 75% of his current level for the duration of his leave while keeping him eligible for standard employee benefits.

The company also detailed a Separation Agreement with former employee Laurie Myers following the end of her employment on August 7, 2025. Subject to her not revoking a release of claims within seven days, Ms. Myers will receive separation pay of $436,720 in semi-monthly installments over 12 months, her unvested stock options will vest and remain exercisable for their full term, and she remains bound by confidentiality, noncompetition, nonsolicitation, and non-disparagement obligations.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
12.00%
Tags
current report
-
Rhea-AI Summary

Cingulate Inc. reported interim financials showing significant operating losses and active equity financings. The company recorded operating loss of $8,356,009 for the six-month period and a loss before income taxes of $(4,788,735) for the three-month period, with an accumulated deficit of approximately $117.1 million. Cash-raising activity included at-the-market sales and Lincoln Park purchase agreements providing net proceeds (examples: $2,599,099 under the ATM during six months ended June 30, 2025 and $3,513,236 under the Original LP Purchase Agreement during the same period). The company disclosed a $5.48 million unsecured promissory note with a 9% coupon and material default penalty mechanics. Management stated there is substantial doubt about the company’s ability to continue as a going concern within one year and noted efforts to seek additional equity, debt, or strategic transactions. The financial statements are unaudited interim results prepared on a going concern basis.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.00%
Tags
quarterly report
-
Rhea-AI Summary

Cingulate Inc. submitted a current report describing that it released financial results for the quarter ended June 30, 2025. On August 19, 2025, the company issued a press release with these quarterly results and recent business highlights, and furnished that press release as Exhibit 99.1. The company notes that this press release is being furnished rather than filed, which limits how it is treated under certain securities law liability provisions and how it is incorporated into other regulatory documents.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.00%
Tags
current report
Rhea-AI Summary

Cingulate Inc. is calling a virtual special meeting on September 25, 2025 to ask stockholders to approve issuing more than 20% of its outstanding common stock under a purchase agreement with Lincoln Park Capital Fund, LLC. This approval is needed to comply with Nasdaq Listing Rule 5635(d) so the company can sell additional shares beyond a 19.99% cap in a private financing.

Under the agreement, Lincoln Park has committed to buy up to $25.0 million of Cingulate common stock over 36 months, and has already received 120,424 commitment shares. As of August 1, 2025, Cingulate had 5,264,642 shares outstanding. The company plans to use any proceeds from sales to Lincoln Park mainly for regulatory approval and development, manufacturing and commercialization activities for CTx-1301, as well as working capital and general corporate purposes. Stockholders are also being asked to approve a potential adjournment of the meeting if more time is needed to gather votes.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.00%
Tags
proxy

FAQ

How many Cingulate (CINGW) SEC filings are available on StockTitan?

StockTitan tracks 70 SEC filings for Cingulate (CINGW). Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Cingulate (CINGW)?

The most recent SEC filing for Cingulate (CINGW) was filed on November 13, 2026.